TransMedics Group, Inc. (TMDX) Net margin 2018–2025
TransMedics Group, Inc. (TMDX) net profit margin by fiscal year — reported net income divided by reported revenue.
31.4%FY2025 · since FY2018: -162.1% → 31.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 31.4% | +23.4 pp |
| FY2024 | 8.0% | +18.4 pp |
| FY2023 | -10.4% | +28.4 pp |
| FY2022 | -38.8% | +102.1 pp |
| FY2021 | -140.9% | -39.5 pp |
| FY2020 | -101.4% | +28.4 pp |
| FY2019 | -129.8% | +32.3 pp |
| FY2018 | -162.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TMDX financial trends
TMDX RevenueTMDX Net incomeTMDX Gross profitTMDX Gross marginTMDX Operating incomeTMDX Operating marginTMDX Operating cash flowTMDX Free cash flowTMDX Capital expendituresTMDX Return on equityTMDX Stock buybacksTMDX Dividends paidTMDX Total assetsTMDX Total liabilitiesTMDX Shareholders’ equityTMDX overview →